The Goa Facility, Which Manufacturing a range of finished products Including oral solids and Injectables, account for more than 30 percent Of Luipn's U.S. Sales. Upon Reporting The News , Lupin saw its stock rise eight percent erasing its entire Previous week's losses.
The battles between FDA and Lupin include the agency citing the Goa Facility after discovering nine obeservation including three involving facility and equipments systems three related to the production system and individual citations for the laboratory control aystem, Quality system and materials Systems.
In March, Lupin's Madideep Production facility received a 483 letter after an inspection in february
The FDA adopted ICH Q10 for Good reason: The lifecycle approach to drug GMP Promises to improve quality across the board. A Process Approach to pharmaceutical Quality System walks your step by step through the Processes and procedure you'II need to put in place.
Lupin manufacturing, fda
.jpg)
